
Synbiotic Treatment Significantly Reduces Infant Sepsis Deaths in India
A new study suggested that neonatal sepsis, which kills 1 million infants around the world each year, may be prevented with synbiotic treatment.
In India, where young infant fatalities due to sepsis are all too common, researchers recently conducted a study indicating that the risk of sepsis can be decreased with a combination of probiotics and prebiotics.
In 2009, the
Researchers from the University of Nebraska Medical Center, in conjunction with researchers at various institutions in India, recently conducted a study in which they were able to significantly reduce neonatal sepsis deaths.
In the
The study’s lead author, Pinaki Panigrahi, MD, PhD, says that this study is the result of about 20 years of work researching neonatal sepsis, after finding in seminal observations that the cause of such deadly infections was an absence of good bacteria and low bacterial diversity in infants’ guts.
“In other words, it is not the presence of any virulent bug that caused disease, rather, absence of good bacteria that could have prevented disease,” Dr. Panigrahi explained in an interview with Contagion®. After conducting surveillance in parts of India where infant sepsis deaths occur most, he worked to screen 280 probiotic strains to find one that effectively blocked colonization and invasion by bacterial pathogens in infants’ intestines, eventually identifying L. plantarum as an effective candidate. “We then mixed this with FOS to provide the food these bacteria need in the colon and conducted another hospital-based trial. This time, the synbiotic combination colonized for up to four months in the infant gut, and we launched the large trial to test its effectiveness.”
The researchers followed the infants in the trial for the first 60 days of life and observed a 40%
“We have shown the scientific evidence, and also from an operational standpoint this can be delivered at home with assistance from village level volunteers,” said Dr. Panigrahi to Contagion®, noting that his team’s findings may have potential impact on other chronic diseases linked to gut bacteria. “We can probably stop overcrowding of the GI tract and repeated GI infections in early childhood, and in turn, a condition called tropical enteropathy or gut dysfunction that gives rise to stunting. This will be even a much bigger contribution to the health and development of any society.”
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

















































































































































































































































































